O'Shaughnessy Asset Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

O'Shaughnessy Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $99,435 - $104,470	-686 Reduced 30.01%	1,600 $242,000
Q2 2022 Aug 11, 2022	BUY	$83.14 - $145.99 $22,281 - $39,125	268 Added 13.28%	2,286 $333,000
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $3,302 - $4,287	30 Added 1.51%	2,018 $239,000
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $64,746 - $90,986	-655 Reduced 24.78%	1,988 $277,000
Q2 2021 Aug 09, 2021	BUY	$65.78 - $105.02 $328 - $525	5 Added 0.19%	2,643 $256,000
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $37,416 - $53,582	-584 Reduced 18.13%	2,638 $180,000
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $208,289 - $314,466	3,201 Added 15242.86%	3,222 $276,000
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $609 - $1,558	21 New	21 $2,000
Q1 2020 May 13, 2020	SELL	$27.51 - $57.29 $825 - $1,718	-30 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$40.86 - $57.65 $1,225 - $1,729	30 New	30 $2,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.